The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?

Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors. If feasible, surgery is the preferred treatment modality. Nevertheless, some malignancies have a tendency of recurrence, with possible distant metastasis. Alternative treatment strategies, such as p...

Descripción completa

Detalles Bibliográficos
Autores principales: Cleymaet, Robbert, Vermassen, Tijl, Coopman, Renaat, Vermeersch, Hubert, De Keukeleire, Stijn, Rottey, Sylvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740091/
https://www.ncbi.nlm.nih.gov/pubmed/36499216
http://dx.doi.org/10.3390/ijms232314891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740091/
https://www.ncbi.nlm.nih.gov/pubmed/36499216
http://dx.doi.org/10.3390/ijms232314891

Ejemplares similares